APA (7th ed.) Citation

K, K., SW, S., Y, J., S, C., J, C., S, J., . . . HS, G. (2026). Phase I Trial of IL13Rα2-Targeted CAR T-cell Therapy for Recurrent Malignant Glioma: Clinical Results and Pharmacokinetics. Clinical cancer research : an official journal of the American Association for Cancer Research, 32(20), 4656. https://doi.org/10.1158/1078-0432.CCR-26-0645

Chicago Style (17th ed.) Citation

K, Kim, et al. "Phase I Trial of IL13Rα2-Targeted CAR T-cell Therapy for Recurrent Malignant Glioma: Clinical Results and Pharmacokinetics." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 32, no. 20 (2026): 4656. https://doi.org/10.1158/1078-0432.CCR-26-0645.

MLA (9th ed.) Citation

K, Kim, et al. "Phase I Trial of IL13Rα2-Targeted CAR T-cell Therapy for Recurrent Malignant Glioma: Clinical Results and Pharmacokinetics." Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 32, no. 20, 2026, p. 4656, https://doi.org/10.1158/1078-0432.CCR-26-0645.